FDA Approved: LAMOTRIGINE — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for lamotrigine from Ajanta Pharma USA Inc. under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)